
    
      The aim of the present prospective, randomized, triple-blind controlled clinical trial was to
      evaluate the efficacy of an innovative mouthwash (emulsion) in the treatment of lesions of
      oral mucosae due to removable prostheses. The tested preparation contained two active
      molecules: a topical antiseptic (0.1% hexetidine) and a local anesthetic (0.5%
      chlorobutanol).
    
  